Scotts Miracle-Gro Co (SMG) Stock Price & Analysis
Scotts Miracle-Gro Co (SMG) rose 2.64% to USD 69.31 as of July 25, 2026 at 06:09 UTC, according to Nexqual real-time market data.
SMG last closed at USD 67.53; the session ranged USD 67.1–69.87 on volume of 698,848 shares. Market capitalization is $4.03B, with a 52-week range of USD 52–75.34 (NYQ). Source: Nexqual, July 25, 2026 at 06:09 UTC.
Key Statistics (as of July 25, 2026 at 06:09 UTC)
| Price | USD 69.31 |
|---|---|
| Change | ▲ 2.64% (up) |
| Previous Close | USD 67.53 |
| Open | USD 67.61 |
| Day Range | USD 67.1 – 69.87 |
| 52-Week Range | USD 52 – 75.34 |
| Volume | 698,848 shares |
| Market Cap | $4.03B |
| Exchange | NYQ |
Technical Analysis (SMG)
Nexqual's technical model rates SMG "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 06:09 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.59 (neutral) |
| vs SMA50 | Above (USD 63.32) |
| MACD | 1.43 (positive) |
Analyst Ratings (SMG)
Wall Street analysts rate SMG "Buy" based on 6 analysts, with a mean price target of USD 74.17 (range USD 67–80), per Nexqual as of July 25, 2026 at 06:09 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 74.17 |
| High Target | USD 80 |
| Low Target | USD 67 |
| Buy / Hold / Sell | 4 / 4 / 0 |
Earnings (SMG)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 2.52 |
| Revenue Estimate | $1.17B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 4.53 vs est 4.01 ▲ beat |
| 2025-12-31 | USD -0.77 vs est -1 ▲ beat |
| 2025-09-30 | USD -1.96 vs est -1.98 ▲ beat |
| 2025-06-30 | USD 2.59 vs est 2.26 ▲ beat |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Financials & Fundamentals (SMG)
| Total Revenue | $3.47B |
|---|---|
| Revenue Growth (YoY) | +5.00% |
| Gross Margin | +32.49% |
| Operating Margin | +27.68% |
| Profit Margin | +3.19% |
| Current Ratio | 1.27 |
| Total Cash | $6.20M |
| Total Debt | $2.67B |
| Free Cash Flow | $411.64M |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Financial Health Score (SMG)
Nexqual rates Scotts Miracle-Gro Co's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:09 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 32%, operating 28% |
| Balance Sheet | Mixed — $6M cash vs $2.67B debt |
| Cash Flow | Solid — FCF $412M, 12% margin |
| Efficiency | Mixed — No data |
Ownership (SMG)
| Insider Ownership | +23.72% |
|---|---|
| Institutional Ownership | +81.99% |
| Shares Outstanding | 58.18M |
| Float | 44.50M |
| Short % of Float | +11.66% |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Leadership (SMG)
Scotts Miracle-Gro Co is led by Nathan Eric Baxter (age 52), CEO, President & Director, per Nexqual as of July 25, 2026 at 06:09 UTC.
| CEO, President & Director | Nathan Eric Baxter (age 52) |
|---|---|
| Executive VP, CFO & Chief Accounting Officer | Mark J. Scheiwer (age 50) |
| Vice President of Treasury, Tax & Investor Relations | Brad Chelton |
| Senior Vice President of Research & Development | Dave Swihart |
| Senior Vice President of International Sales | Phil Jones |
Major Backers & Investors (SMG)
Notable institutional backers of Scotts Miracle-Gro Co include Earnest Partners LLC, FMR, LLC, Fidelity, according to Nexqual as of July 25, 2026 at 06:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Earnest Partners LLC | 5.84% |
| FMR, LLC | 3.68% |
| Fidelity | 2.74% |
| Ameriprise Financial, Inc. | 2.42% |
| Arrowstreet Capital, Limited Partnership | 2.22% |
| CAPTRUST Financial Advisors | 2.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 13.73% |
| BlackRock | 10.25% |
| State Street | 3.2% |
| Northern Trust | 1.89% |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
From Scotts Miracle-Gro Co's Latest SEC 10-K Filing (filed 2025-11-25)
Key Strengths & Strategy (as disclosed to the SEC)
- The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally.
- The company provides lawn care products, comprising lawn fertilizers, clover and grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions.
- It also offers hydroponic products that help users to grow plants, flowers, and vegetables using little or no soil; lighting systems and components; insect, rodent, and weed control products for home areas; and non-selective weed killer products.
- It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, and food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IIPR | Innovative Industrial Propertie | USD 61.48 | ▼ 1.33% |
| CRON | Cronos Group Inc. Common Share | USD 2.81 | ▲ 1.08% |
| STZ | Constellation Brands, Inc. | USD 130.16 | ▼ 1.45% |
| TVRD | Tvardi Therapeutics, Inc. | USD 2.51 | ▼ 9.06% |
| GRWG | GrowGeneration Corp. | USD 1.38 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:09 UTC. This page is informational and not investment advice.